VYOME HOLDINGS, INC. Revenue from Contract with Customer, Excluding Assessed Tax
VYOME HOLDINGS, INC. (HIND) reported Revenue from Contract with Customer, Excluding Assessed Tax of $1.24 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2025-08-14
- VYOME HOLDINGS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-06-30 was $1.24M, a 36.79% decline year-over-year.
- VYOME HOLDINGS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-03-31 was $1.11M, a 42.75% decline year-over-year.
- VYOME HOLDINGS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2024-12-31 was $1.80M, a 8.93% decline year-over-year.
- VYOME HOLDINGS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2024-09-30 was $2.29M, a 6.36% increase year-over-year.
- VYOME HOLDINGS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $8.01M, a 7.74% decline from fiscal 2023.
- VYOME HOLDINGS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $8.68M, a 22.79% decline from fiscal 2022.
- VYOME HOLDINGS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $11.24M, a 17.35% decline from fiscal 2021.
- VYOME HOLDINGS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2021 was $13.60M, a 20.36% increase from fiscal 2020.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 3 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 12 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | $1.24M 10-Q · filed 2025-08-14 | $2.35M 10-Q · filed 2025-08-14 | $4.16M derived: sum of 3 quarters · filed 2025-08-14 | $6.45M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2025-03-31 | $1.11M 10-Q · filed 2025-05-20 | $2.92M derived: sum of 2 quarters · filed 2025-05-20 | $5.21M derived: sum of 3 quarters · filed 2025-05-20 | $7.17M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | $4.10M derived: sum of 2 quarters · filed 2025-04-04 | $6.06M derived: sum of 3 quarters · filed 2025-08-14 | $8.01M 10-K · filed 2025-04-04 | ||||
| 2024-09-30 | $2.29M 10-Q · filed 2024-11-14 | $4.26M derived: sum of 2 quarters · filed 2025-08-14 | $6.20M 10-Q · filed 2024-11-14 | $8.18M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-06-30 | $1.97M 10-Q · filed 2025-08-14 | $3.91M 10-Q · filed 2025-08-14 | $5.89M derived: sum of 3 quarters · filed 2025-08-14 | $8.05M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $1.94M 10-Q · filed 2025-05-20 | $3.93M derived: sum of 2 quarters · filed 2025-05-20 | $6.08M derived: sum of 3 quarters · filed 2025-05-20 | $8.34M derived: sum of 4 quarters · filed 2025-05-20 | ||||
| 2023-12-31 | $1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | $4.14M derived: sum of 2 quarters · filed 2025-04-04 | $6.39M derived: sum of 3 quarters · filed 2025-04-04 | $8.68M 10-K · filed 2025-04-04 | ||||
| 2023-09-30 | $2.15M 10-Q · filed 2024-11-14 | $4.41M derived: sum of 2 quarters · filed 2024-11-14 | $6.70M 10-Q · filed 2024-11-14 | $9.81M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $2.25M 10-Q · filed 2024-08-14 | $4.54M 10-Q · filed 2024-08-14 | $7.65M derived: sum of 3 quarters · filed 2024-08-14 | $10.45M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $2.29M 10-Q · filed 2024-05-15 | $5.40M derived: sum of 2 quarters · filed 2024-05-15 | $8.20M derived: sum of 3 quarters · filed 2024-05-15 | $11.09M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $3.11M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $5.91M derived: sum of 2 quarters · filed 2024-04-01 | $8.80M derived: sum of 3 quarters · filed 2024-04-01 | $11.24M 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | $2.80M 10-Q · filed 2023-11-09 | $5.69M derived: sum of 2 quarters · filed 2023-11-09 | $8.13M 10-Q · filed 2023-11-09 | $11.27M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | $2.89M 10-Q · filed 2023-08-07 | $5.33M 10-Q · filed 2023-08-07 | $8.47M derived: sum of 3 quarters · filed 2023-08-07 | $12.18M derived: sum of 4 quarters · filed 2023-08-07 | ||||
| 2022-03-31 | $2.44M 10-Q · filed 2023-05-15 | $5.58M derived: sum of 2 quarters · filed 2023-05-15 | $9.29M derived: sum of 3 quarters · filed 2023-05-15 | $12.82M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $3.14M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $6.85M derived: sum of 2 quarters · filed 2023-04-17 | $10.38M derived: sum of 3 quarters · filed 2023-04-17 | $13.60M 10-K · filed 2023-04-17 | ||||
| 2021-09-30 | $3.71M 10-Q · filed 2022-11-14 | $7.24M derived: sum of 2 quarters · filed 2022-11-14 | $10.46M 10-Q · filed 2022-11-14 | $13.66M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $3.53M 10-Q · filed 2022-08-19 | $6.75M 10-Q · filed 2022-08-19 | $9.96M derived: sum of 3 quarters · filed 2022-08-19 | $13.56M derived: sum of 4 quarters · filed 2022-08-19 | ||||
| 2021-03-31 | $3.22M 10-Q · filed 2022-05-23 | $6.43M derived: sum of 2 quarters · filed 2022-05-23 | $10.03M derived: sum of 3 quarters · filed 2022-05-23 | $11.73M derived: sum of 4 quarters · filed 2022-05-23 | ||||
| 2020-12-31 | $3.21M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $6.81M derived: sum of 2 quarters · filed 2022-04-08 | $8.51M derived: sum of 3 quarters · filed 2022-04-08 | $11.30M 10-K · filed 2022-04-08 | $1.59M 10-K · filed 2021-03-12 | |||
| 2020-09-30 | $3.60M 10-Q · filed 2021-11-12 | $44.00K 10-Q · filed 2020-11-06 | $5.30M derived: sum of 2 quarters · filed 2021-11-12 | $8.09M 10-Q · filed 2021-11-12 | $1.53M 10-Q · filed 2020-11-06 | $6.87M derived: sum of 4 quarters · filed 2021-11-12 | ||
| 2020-06-30 | $1.70M 10-Q · filed 2021-08-16 | $703.00K 10-Q · filed 2020-07-30 | $4.49M 10-Q · filed 2021-08-16 | $1.48M 10-Q · filed 2020-07-30 | $3.27M derived: sum of 3 quarters · filed 2021-08-16 | $3.60M derived: sum of 4 quarters · filed 2021-08-16 | ||
| 2020-03-31 | $780.00K 10-Q · filed 2021-05-12 | $1.57M derived: sum of 2 quarters · filed 2021-05-12 | $1.90M derived: sum of 3 quarters · filed 2021-05-12 | $2.29M derived: sum of 4 quarters · filed 2021-05-12 | ||||
| 2019-12-31 | $787.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $1.12M derived: sum of 2 quarters · filed 2021-03-12 | $1.51M derived: sum of 3 quarters · filed 2021-03-12 | $3.28M 10-K · filed 2021-03-12 | ||||
| 2019-09-30 | $333.00K 10-Q · filed 2020-11-06 | $719.00K derived: sum of 2 quarters · filed 2020-11-06 | $2.49M 10-Q · filed 2020-11-06 | $4.53M derived: sum of 4 quarters · filed 2020-11-06 | ||||
| 2019-06-30 | $386.00K 10-Q · filed 2020-07-30 | $2.16M 10-Q · filed 2020-07-30 | $4.20M derived: sum of 3 quarters · filed 2020-07-30 | $7.18M derived: sum of 4 quarters · filed 2020-07-30 | ||||
| 2019-03-31 | $1.77M 10-Q · filed 2020-06-19 | $3.81M derived: sum of 2 quarters · filed 2020-06-19 | $6.80M derived: sum of 3 quarters · filed 2020-06-19 | $9.53M derived: sum of 4 quarters · filed 2020-06-19 | ||||
| 2018-12-31 | $2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $5.02M derived: sum of 2 quarters · filed 2020-02-27 | $7.75M derived: sum of 3 quarters · filed 2020-02-27 | $9.10M 10-K · filed 2020-02-27 | ||||
| 2018-09-30 | $2.99M 10-Q · filed 2019-11-08 | $5.72M derived: sum of 2 quarters · filed 2019-11-08 | $7.07M 10-Q · filed 2019-11-08 | $10.76M derived: sum of 4 quarters · filed 2019-11-08 | ||||
| 2018-06-30 | $2.73M 10-Q · filed 2019-07-24 | $4.08M 10-Q · filed 2019-07-24 | $7.77M derived: sum of 3 quarters · filed 2019-07-24 | $10.56M derived: sum of 4 quarters · filed 2019-07-24 | ||||
| 2018-03-31 | $1.35M 10-Q · filed 2019-05-10 | $5.04M derived: sum of 2 quarters · filed 2019-05-10 | $7.83M derived: sum of 3 quarters · filed 2019-05-10 | $9.79M derived: sum of 4 quarters · filed 2019-05-10 | ||||
| 2017-12-31 | $3.69M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $6.48M derived: sum of 2 quarters · filed 2019-02-22 | $8.44M derived: sum of 3 quarters · filed 2019-02-22 | $9.91M 10-K · filed 2019-02-22 | ||||
| 2017-09-30 | $2.79M 10-Q · filed 2018-11-02 | $4.75M derived: sum of 2 quarters · filed 2018-11-02 | $6.22M 10-Q · filed 2018-11-02 | |||||
| 2017-06-30 | $1.96M 10-Q · filed 2018-08-02 | $3.44M 10-Q · filed 2018-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |